LifeStance Therapists & Psychiatrists Smyrna
400 Technology Court Southeast, Suite j, Smyrna
4.4(666 Google reviews)
United States
7 listed treatment centers serving Smyrna and the surrounding area.
400 Technology Court Southeast, Suite j, Smyrna
4.4(666 Google reviews)
400 Technology Court Southeast, Suite j, Smyrna
4.9(29 Google reviews)
400 Technology Court Southeast, Suite j, Smyrna
4.9(14 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Smyrna.
2.2 miles away · Marietta
3.3 miles away · Atlanta
4.6 miles away · Marietta
4.6 miles away · Marietta
8.3 miles away · Sandy Springs
1200 Altmore Avenue, Suite 200, Sandy Springs
4.5(465 Google reviews)
8.6 miles away · Atlanta
For people in Smyrna considering SPRAVATO®, costs depend on insurance benefits, the treatment setting, and the prescribed schedule. Both the medication and the visit for administration and required observation may be billed. Ask for an estimate that includes both, rather than assuming a medication quote covers the whole appointment.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medicines you tried and how you responded. Ask the treatment center who submits this paperwork, which records you should provide, and whether authorization is needed before scheduling treatment. Authorization does not necessarily mean every charge will be paid.
Medicare coverage may involve Part B or Part D, depending on the plan and setting. Georgia Medicaid coverage also depends on the plan and setting. The seven Smyrna listings currently indicate that they do not accept Medicare or Medicaid; confirm directly before making plans. A program's possible coverage and a center's acceptance of that coverage are separate questions.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Eligibility rules apply; ask about current terms rather than assuming assistance is available.
Before starting, ask the center and insurer:
SPRAVATO® visits take place in a healthcare setting certified through the restricted SPRAVATO® REMS program. You administer the nasal spray yourself under a healthcare provider's direct observation; it is never sent home. Smyrna has seven listed centers offering Spravato, but their REMS certification status is not recorded in the supplied listings. Confirm certification and appointment availability directly.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines your schedule; do not assume visits will become less frequent on a fixed date.
Allow more than two hours for an appointment: monitoring alone lasts at least two hours after each dose, and check-in, preparation, or longer observation can add time. Ask how much time to reserve before requesting leave from work or arranging childcare. If your work involves driving or machinery, discuss scheduling around those duties.
Arrange for someone else to drive you home after every visit. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its pickup requirements, confirm your ride in advance, and have a backup person available if possible.
If a future search shows no Smyrna listing, or local appointments are unavailable, you can investigate listed options in Marietta, Sandy Springs, Atlanta, Roswell, Alpharetta, or Johns Creek. Confirm certification, insurance acceptance, and availability before committing. Compare the full recurring travel and appointment burden, not just whether an initial visit is available.
There are seven Smyrna listings offering SPRAVATO®, but their REMS certification status is not recorded in the supplied directory information. Ask each center to confirm current certification before scheduling treatment. Also check whether it is accepting new patients and can accommodate repeated visits. If local options do not work, investigate listings in Marietta, Sandy Springs, or Atlanta, confirming the same details.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved, together with an oral antidepressant, for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior. It is not approved for children. A clinician must review your diagnosis, treatment history, and safety considerations; a directory listing cannot establish eligibility.
Coverage may be available through Medicare Part B or Part D or Georgia Medicaid, depending on your plan and treatment setting. However, the supplied Smyrna listings indicate that none of the seven centers accepts Medicare or Medicaid. Confirm directly because participation can change. Ask your insurer about participating treatment settings and whether both the medication and monitoring visit require authorization.
You self-administer the nasal spray under direct observation at a REMS-certified healthcare setting. Staff monitor you for at least two hours afterward, including checks for sedation, dissociation, breathing problems, and blood pressure increases. The full appointment can take longer. Arrange a ride home: you cannot drive or operate machinery until the next day after a restful sleep.
Ask about sedation, dissociation—feeling disconnected from yourself or your surroundings—breathing problems, and blood pressure increases. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your health history, medicines, and any substance-use concerns with the clinician, and report symptoms promptly during monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Its approved use for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior requires an oral antidepressant. If you are in crisis, call or text 988. For immediate danger or a medical emergency, call 911 rather than waiting for an appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.